VAERS reports by lot

GSK Varicella/Shingles lot F4234: VAERS reports

26 VAERS reports list lot F4234 as a GSK Varicella/Shingles vaccine, received between 2020-05-21 and 2021-12-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
4%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1624%
General / Systemic (non-local)1522%
Allergic / Anaphylactic1015%
Neurological710%
Dermatological (non-injection-site)710%
Musculoskeletal57%
Gastrointestinal34%
Cardiac / Cardiovascular23%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania7
Oregon2
Washington2
Wisconsin2
New York2
Nebraska1
Georgia1
North Dakota1
New Mexico1
New Hampshire1
Missouri1
Delaware1

Reports by month received

2020-052
2020-061
2020-075
2020-083
2020-097
2020-102
2021-011
2021-051
2021-061
2021-072
2021-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.